职业与健康 ›› 2026, Vol. 42 ›› Issue (15): 2048-2052.

• 论著—实验·监测与检验 • 上一篇    下一篇

赶黄草桂圆复合奶片安全性评价及对Ⅱ型糖尿病小鼠的影响研究

李辉1, 严忠翠1, 李兴平1, 周丽霞1, 黄家雨2, 谢惠波1()   

  1. 1 四川三河职业学院四川 泸州 646200
    2 泸州欣旺动物医院有限公司四川 泸州 646000
  • 收稿日期:2025-03-11 修回日期:2025-08-18 出版日期:2026-08-01 发布日期:2026-07-16
  • 通信作者: 谢惠波
  • 作者简介:李辉,男,助教,主要从事食品营养与健康教研工作。
  • 基金资助:
    泸州市科技计划项目(2021-SYF-39);四川省科技创新苗子工程项目(MZGC20240101)

Effects of Penthorum chinense-Longan milk tablet on Type Ⅱ diabetic mice and safety assessment

LI Hui1, YAN Zhongcui1, LI Xingping1, ZHOU Lixia1, HUANG Jiayu2, XIE Huibo1()   

  1. 1 Sichuan Sanhe College of ProfessionalsLuzhouSichuan 646200, China
    2 Luzhou Xinwang Laboratory of Animal Hospital Co.Ltd,LuzhouSichuan 646000, China
  • Received:2025-03-11 Revised:2025-08-18 Online:2026-08-01 Published:2026-07-16
  • Contact: XIE Huibo
  • About author:XIE Huibo,E-mail:1773664395@qq.com

摘要:

目的 评估赶黄草桂圆奶片的安全性及其对Ⅱ型糖尿病小鼠的干预效果,为功能性食品开发提供参考依据。方法 采用SPF级健康昆明小鼠30只,于2024年5月1—7日进行7天急性毒性实验,随机分为实验组(n=15)和对照组(n=15);实验组每日灌胃相当于0.05 g/kg赶黄草的奶片溶液(按体表面积折算自成人8 g/60 kg日摄入量),对照组常规喂养,检测体质量、各系统症状及存活率,评估产品安全性。于2024年5月8日—6月7日进行30天灌胃功效验证实验:将10只正常昆明小鼠、10只db/dbⅡ型糖尿病小鼠分别随机分为实验组(各n=5)和对照组(各n=5),共4组;实验组每日灌胃0.3 mL奶片溶液(1.8 g奶片溶解于10 mL水配制),对照组常规喂养,检测总蛋白、白蛋白、球蛋白、血糖等核心生化指标及体质量变化。结果 急性毒性实验中,实验组小鼠无异常行为或死亡,体质量增长与对照组无差异,存活率100.0%。功效验证实验中正常小鼠:干预30天后,总蛋白显著提升23.7%(分别为56.93和70.40 g/L,t=5.242,P<0.05),白蛋白增加32.0%(分别为25.0和33.0 g/L,t=6.151,P<0.05),血糖短暂升高至5.28 mmol/L(t=9.491,P<0.01),仍低于糖尿病阈值。db/dbⅡ型糖尿病小鼠:完全抑制对照组61.3%的蛋白流失(从14.10到57.37 g/L,F交互=121.583,P<0.01),球蛋白提升10.8%(分别是34.23和37.93 g/L,t=3.424,P<0.05),维持血糖稳态(t=1.123,P>0.05),避免对照组危险低血糖(1.4 mmol/L,t=-4.021,P<0.05)。结论 赶黄草桂圆复合奶片具有良好的安全性,其通过赶黄草抑制肌肉分解及桂圆、奶粉促进蛋白合成的协同作用,对Ⅱ型糖尿病小鼠能显著改善蛋白质代谢紊乱,并维持血糖稳态。该产品体现了中医“肝脾同调”理念,为代谢综合征的干预提供了兼具安全性与功能性的创新策略,具备作为功能性食品辅助改善相关代谢异常的应用潜力。

关键词: 赶黄草, 桂圆, 奶片, Ⅱ型糖尿病, 营养补充, 代谢综合征

Abstract:

Objective To evaluate the safety of Penthorum chinense-Longan milk tablet and their intervention effects on type Ⅱ diabetic mice,so as to provide a reference for the development of functional food. Methods From May 1-7,2024,a 7-day acute toxicity tests were conducted on 30 healthy SPF Kunming mice. The mice were randomly divided into an experimental group(n=15) and a control group(n=15). The experimental group was given a daily gavage of a milk tablet solution equivalent to 0.05 g/kg of Penthorum chinense-Longan(equivalent to 8 g/60 kg daily intake for adults based on body surface area),while the control group was given regular feeding. The body weight,various system symptoms,and survival rate were tested to evaluate the safety of the product. From May 8 to June 7,2024,the efficacy verification experiment of 30 day intragastric administration was carried out. 10 normal Kunming mice and 10 db/db type II diabetes mice were randomly divided into experimental group(n=5) and control group(n=5),a total of 4 groups. The experimental group was given 0.3 mL of milk tablet solution by gavage daily(1.8 g milk tablets dissolved in 10 mL of water),while the control group was given routine feeding. Core biochemical indicators such as total protein,albumin,globulin,and blood glucose,as well as changes in body weight,were measured. Results In the acute toxicity test,no abnormal behaviors or mortality were observed in the experimental group. Body weight gain showed no significant difference compared to the control group,with a 100.0% survival rate. In the efficacy validation experiment,after 30 days of intervention,the total protein of normal mice significantly increased by 23.7%(56.93 vs 70.40 g/L,t=5.242,P<0.05),albumin increased by 32.0%(25.0 vs 33.0 g/L,t=6.15,P<0.05),and the blood glucose temporarily increased to 5.28 mmol/L(t=9.491,P<0.01),still lower than the threshold of diabetes. For db/db type Ⅱ diabetic mice,it completely inhibited 61.3% protein loss in the control group(from 14.10 to 57.37 g/L,Finteraction=121.58,P<0.01),increased the globulin by 10.8%(34.23 vs 37.93 g/L,t=3.424,P<0.05),maintained blood glucose homeostasis(t=1.123,P>0.05),and avoided the dangerous hypoglycemia(1.4 mmol/L,t=-4.021,P<0.05) observed in the control group. Conclusion The Penthorum chinense-Longan milk tablet demonstrates excellent safety. Through synergistic mechanisms-Penthorum chinense flavonoids inhibiting muscle protein degradation and longan polysaccharides/milk powder promoting protein synthesis,the product significantly improve the disorder of protein metabolism and maintain glycemic homeostasis in type II diabetic mice. This formulation embodies the traditional Chinese medicine theory of "liver-spleen dual regulation" and provides an innovative strategy for the intervention of metabolic syndrome that combines safety and functionality. It holds substantial potential as a functional food for alleviating diabetes-related metabolic abnormalities.

Key words: Penthorum chinense, Longan, Milk slices, Type II diabetes, Nutritional supplement, Metabolic syndrome

中图分类号: